I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-40.17%
Change (1 year)
Categories
Operating Margin for I-Mab Biopharma (IMAB)
Operating Margin as of May 2024 (TTM): -2,652.27%
According to I-Mab Biopharma's latest financial reports and stock price the company's current Operating Margin is -2,652.27%. At the end of 2021 the company had an Operating Margin of -2,652.28%.
Operating Margin history for I-Mab Biopharma from 2020 to 2020
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,652.28% | -8551.89% |
| 2020 | 31.38% | -100.65% |
| 2019 | -4,829.86% | 567.04% |
| 2018 | -724.08% | -71.4% |
| 2017 | -2,531.99% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -98.63% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 216.38% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.